Get the Stockscreener App
0.0002
50.00%
-0.0002
Clever Leaves Holdings Inc stock is traded at $0.0002, with a volume of 2,684.
It is down -50.00% in the last 24 hours and down -21.65% over the past month.
See More
Previous Close:
$0.0004
Open:
$0.0002
24h Volume:
2,684
Relative Volume:
44.73
Market Cap:
$N/A
Revenue:
$18.57M
Net Income/Loss:
$-41.63M
P/E Ratio:
-0.000007
EPS:
-29.36
Net Cash Flow:
$-14.70M
1W Performance:
-50.00%
1M Performance:
-21.65%
6M Performance:
+45.70%
1Y Performance:
+1,165%
1-Day Range:
$0.0002
$0.0002
1-Week Range:
$0.0002
$0.0002
52-Week Range:
$0.0002
$0.0004
Clever Leaves Holdings Inc Stock (CLVR) Company Profile
Compare CLVR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLVR
Clever Leaves Holdings Inc
|
0.0002 | 0 | 18.57M | -41.63M | -14.70M | -29.36 |
|
ZTS
Zoetis Inc
|
151.39 | 70.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.68 | 47.44B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.715 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.91 | 19.07B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.15 | 13.28B | 2.99B | 1.21B | 1.13B | 25.06 |
Clever Leaves Holdings Inc Stock (CLVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-27-21 | Initiated | Canaccord Genuity | Buy |
| Jul-23-21 | Initiated | Cowen | Market Perform |
Clever Leaves Holdings Inc Stock (CLVR) Latest News
Jordan Salzman - Freshfields
China Liberal Education (NASDAQ:CLEU) Shares Gap DownShould You Sell? - MarketBeat
China Liberal Education (NASDAQ:CLEU) Sets New 12-Month LowHere's What Happened - MarketBeat
Cannabis Company Clever Leaves Reports Q4 And 2023 Results: Revenue Growth And Expense Reductions - MSN
Clever Leaves : to Webcast Live at VirtualInvestorConferences.com September 9th - Marketscreener.com
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study - Investing News Network
Leafly delisted from Nasdaq - Green Market Report
The 5 Best Marijuana Stocks Under $10 in 2025 - CoinCodex
Cannabis rescheduling opposed by some DEA officials: WSJ - MSN
Comparing MariMed (OTCMKTS:MRMD) & Clever Leaves (NASDAQ:CLVRW) - Defense World
M&A Drought Leaves Bankers at the Mercy of Private-Equity Firms - BNN Bloomberg
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify - Benzinga
Nasdaq just says no to penny stocks - Green Market Report
Leafly at risk of Nasdaq delisting, plans appeal - Crain's Chicago Business
Cannabis Companies Delisted From Major Stock Exchanges In 2024: What Went Wrong? - Benzinga
Rising High: SNDL announces successful bid to acquire Indiva - TipRanks
Cannabis In Venezuela: Will Legalization Ever Be Possible?Clever Leaves Holdings (OTC:CLVR), Khiron Life Sciences (OTC:KHRNF) - Benzinga
Clever Leaves Cannabis Company Exits NASDAQ Amid Financial Strains, Stock Plunges -60%, Investors ImpactedClever Leaves Holdings (OTC:CLVR) - Benzinga
Cannabis rescheduling imminent, opponents say (Newsletter: April 30, 2024) - Marijuana Moment
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session - TradingView
Clever Leaves to delist from Nasdaq and end SEC reporting - Investing.com
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - Yahoo Finance
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia - GlobeNewswire
Toronto’s Cronos Group enters Australian market with cannabis shipment to Vitura Health - Mugglehead Magazine
Clever Leaves Scores Australian Cannabis GMP Certification - Hemp Gazette
Clever Leaves Granted Australian GMP Certification for - GlobeNewswire
11 Cheap Pot Stocks to Buy - Yahoo Finance
13 Best Hemp Stocks To Buy Now - Yahoo Finance
12 Best CBD Stocks To Buy Now - Yahoo Finance
Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors - Business Wire
Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder - Business Wire
(SPAC) Special Purpose Acquisition Investigation: Embark - GlobeNewswire
(SPAC) Special Purpose Acquisition Investigation: Katapult, LiveVox, Porch.com, and Clever Leaves. Contact Shareholder Rights Law Firm Johnson Fistel - GlobeNewswire
Cannabis company Leafly completes 1-for-20 reverse stock split to avoid Nasdaq delisting - GeekWire
Aurora Cannabis partners with Brazilian firm to expand CBD portfolio - Mugglehead Magazine
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements - GlobeNewswire
Curaleaf Poised To Dominate German Cannabis Market As Government Moves To Legalize - Benzinga
Global Blockchain Acquisition and Cardea Merging in $175M Deal - DealFlow's SPAC News
Clever Leaves Reports 21% Revenue Growth And 10% Gross Profit Rise In 2Q 2023 - Benzinga
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ET - GlobeNewswire
Meet The Biggest Cannabis Company In Latin America — You’ve Never Heard Of - Forbes
Cannabis Weekly Round-Up: Cronos Exploring Sale Options - Investing News Network
MedMen Appoints New CEO, Chief Financial Officer - Cannabis Business Times
Curaleaf to acquire Portuguese cannabis facility from Clever Leaves - Mugglehead Magazine
Astrasana and Clever Leaves Partner to Establish International Supply Agreement For - Presseportal.ch
Clever Leaves ships first cannabis extracts to Switzerland - Mugglehead Magazine
Clever Leaves sends first cannabis shipment to Portugal - Mugglehead Magazine
Clever Leaves Granted Brazilian GMP Certification for Cannabis Products by ANVISA - GlobeNewswire
Clever Leaves Reports First Quarter 2023 Results - GlobeNewswire
Clever Leaves to Hold First Quarter 2023 Conference Call on Thursday, May 11, 2023 at 5:00 p.m. ET - Yahoo Finance
22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK And EU Market Position - Business of Cannabis -
Clever Leaves Holdings Inc Stock (CLVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.21%
0.62%
Cap:
|
Volume (24h):